European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits

Trial Profile

European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Stroke; Thrombosis; Venous thromboembolism
  • Focus Therapeutic Use
  • Acronyms ECASS4-ExTEND
  • Most Recent Events

    • 01 Sep 2016 Status changed from recruiting to completed.
    • 19 Feb 2016 Trial design presented at the 41st International Stroke Conference
    • 17 Dec 2015 Accrual to date is 12%, according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top